Skip to content

AptarGroup ATR Free cash flow yield

Free cash flow yield at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
2.5%+0.6pp
Amcor logo
AmcorAMCR
4.1%
Nordson logo
NordsonNDSN
4.4%+0.2pp
Baxter International logo
Baxter InternationalBAX
3.4%-0.5pp
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
8.7%+2.4pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
5%

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Calculated from AptarGroup’s reported figures.

Based on trailing twelve months.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's free cash flow yield?
AptarGroup (ATR) reported free cash flow yield of 4.1% in Q1 2026.
How has AptarGroup's free cash flow yield changed year-over-year?
AptarGroup's free cash flow yield increased by 5.9% year-over-year, from 3.8% to 4.1%.
What is the long-term trend for AptarGroup's free cash flow yield?
Over 5 years (2020 to 2025), AptarGroup's free cash flow yield has grown at a 0.8% compound annual growth rate (CAGR), from 3.6% to 3.7%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.